Current practice
James Cherry is a registered patent and trade mark attorney and intellectual property lawyer in Australia and New Zealand. James is a partner of Freehills Patent & Trade Mark Attorneys and of its associated law firm, Freehills.
Within Freehills Patent & Trade Mark Attorneys, James specialises in patent preparation, prosecution and counselling in the technical areas of biotechnology, pharmaceuticals and medical treatments. He advises owners of rights on how to best protect and extract value from their intellectual property. He also advises on the related areas of confidential information, plant breeders’ rights and trade secrets.
Experience
James works with local research organisations and start up companies. James also works with multinational biopharmaceutical corporations in their Australian-New Zealand operations.
James has been involved in significant acquisitions and dispositions of intellectual property rights around the world, as well as advising in international IP disputes. James also actively assists clients in their licensing, patent strategy and technology transfer negotiations worldwide. As the international management of intellectual property rights becomes increasingly important, James advises on strategic creation and exploitation of intellectual property rights worldwide.
Professional background
James is a registered patent and trade mark attorney before the Australian Patent and Trade Marks Office and the Intellectual Property Office of New Zealand. James has a science degree majoring in the biological sciences, including biochemistry, molecular biology, pharmacology, proteins and human nutrition.
He also has a law degree with honours from the University of Melbourne and is admitted as a barrister and solicitor.
Before joining Freehills in 1990, James worked in patent attorney firms in Melbourne, Montreal and London.
James is currently a Fellow of the Institute of Patent and Trade Mark Attorneys of Australia, a member of AIPPI and Licensing Executives Society, as well as a member of local committees concerning biotechnology. He has also lectured for Monash University and regularly presents at seminars and conferences on intellectual property matters relating to biotechnology.
